基本信息
views: 179
Career Trajectory
Bio
主要研究领域为新型抗动脉粥样硬化及抗感染药物筛选模型系统的建立,先导化合物的获得及分子药理学研究。是我国创新微生物药物筛选与发现的学术带头人。先后主持过国家自然科学基金重点项目,十五、十一五、十二五国家重大专项“重大新药创制”项目,“创新微生物药物高效筛选与发现技术平台建设”,使我国创新微生物药物高效筛选的规模和水平到达国际先进水平。在国内外包括Nature medicine, PNAS等主要刊物上发表论文120多篇,其中SCI收录论文80余篇,被引用2000余次。
Research Interests
Papers共 287 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JOURNAL OF NATURAL PRODUCTSno. 2 (2024): 365-370
ACTA PHARMACEUTICA SINICA Bno. 6 (2024): 2567-2580
Ren Sheng,Yining Li,Yexiang Wu,Chang Liu,Weizhi Wang,Xiaowan Han,Yinghong Li,Lijuan Lei,Xinhai Jiang,Yuyan Zhang, Yuhao Zhang,Shunwang Li,Bin Hong, Chao Liu,Yanni Xu,Shuyi Si
BIOMEDICINE & PHARMACOTHERAPY (2024)
Acta Pharmacologica Sinica (2024)
European Journal of Medicinal Chemistry (2024)
Xinhai Jiang,Weizhi Wang, Lijuan Lei,Tingting Feng,Yang Hu,Peng Liu,Yining Li,Ren Sheng,Yuyan Zhang,Shunwang Li,Jing Zhang,Yuhao Zhang, Zheng-gen Jin,Zhuang Tian,Jiandong Jiang,Yanni Xu,Shuyi Si
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCESno. 10 (2024): 3725-3741
Atherosclerosis (2024): 118441-118441
Gao-Jie Li, Chen Wang,Wen-Die Wang,Yue Shang, Chao-Yang Zeng,Ai-Min Wang,Jing-Lin Bai,Jing Su,Ling Su,Shu-Yi Si,Li-Yan Yu,Mao-Luo Gan,Shu-Zhen Chen
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2024)
Yuyan Zhang,Xinhai Jiang,Weizhi Wang,Lijuan Lei,Ren Sheng, Shunwang Li,Jinque Luo,Huan Liu,Jing Zhang,Xiaowan Han,Yining Li, Yuhao Zhang,Chenyin Wang,Shuyi Si, Zheng-Gen Jin,Yanni Xu
Arteriosclerosis, thrombosis, and vascular biology (2024)
Load More
Author Statistics
#Papers: 288
#Citation: 6108
H-Index: 36
G-Index: 71
Sociability: 7
Diversity: 1
Activity: 2
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn